Parameter

Groups

No.

%

t(9; 22) (total No. = 11)

P

Significance

+ve

−ve

No.

%

No.

%

Age (Years)

≥35

<35

18

21

46.2

53.8

9

2

81.8

18.2

9

19

32.1

67.9

0.005

HS

Gender

M/F: 1.6:1

Male

Female

24

15

61.5

38.5

7

4

63.6

36.4

17

11

60.7

39.3

0.866

NS

Hepatomegaly

Yes

No

19

20

48.7

51.3

11

0

100

0

8

20

28.6

71.4

0.000

HS

Splenomegaly

Yes

No

20

19

51.3

48.7

11

0

100

0

9

19

32.1

67.9

0.000

HS

Lymphadenopathy

Yes

No

24

15

61.5

38.5

1

10

9.1

90.9

23

5

82.1

17.9

0.000

HS

CNS Infilteration

Yes

No

2

37

5.1

94.9

1

10

9.1

90.9

1

27

3.6

96.4

0.482

NS

Hb

<10 g/dl

≥10 g/dl

36

3

92.3

7.7

9

2

81.8

18.2

27

1

96.4

3.6

0.123

NS

TLC (×109/L)

<50

≥50

26

13

66.7

33.3

3

8

27.3

72.7

23

5

82.1

17.9

0.001

HS

Platelet count (×109/L)

<100

≥100

33

6

84.6

15.4

11

0

100

0

22

6

78.6

21.4

0.095

NS

Absolute PB Blasts

<4.4

≥4.4

19

20

48.7

51.3

1

10

9.1

90.9

18

10

64.3

35.7

0.002

HS

IPT

CD10:

Positive

Negative

CD13/33:

Positive

Negative

26

13

5

34

66.7

33.3

12.8

87.2

6

5

5

6

54.5

45.5

45.5

54.5

20

8

0

28

71.4

28.6

0

100

0.314

0.000

NS

HS

Other Aberrations

Yes

No

11

28

28.2

71.8

11

0

100

0

0

28

0

100

0.000

HS

Aberrations Type

None

Ampl

Ampl, Del

Del

Dupl

31

3

1

3

1

79.5

7.7

2.6

7.7

2.6

3

3

1

3

1

27.3

27.3

9.1

27.3

9.1

28

0

0

0

0

100

0

0

0

0

0.000

HS